Evaluating Awareness of Low-Dose Computerized Tomography For Lung Cancer Screening

Authors

Roshni LeBoutillier, HCA HealthcareFollow
Bansi Savla, HCA HealthcareFollow
Vincent Wu, HCA HealthcareFollow
Zia Khan, HCA HealthcareFollow
Erick Mejia, HCA HealthcareFollow
Leah Tehranchi, HCA HealthcareFollow
My Myers, HCA HealthcareFollow
Khine Min, HCA HealthcareFollow
Jennifer Broyles, HCA HealthcareFollow
Stacy Chase, HCA HealthcareFollow

Files

Division

West Florida

Hospital

St. Petersburg General Hospital

Specialty

Family Medicine

Document Type

Poster

Publication Date

5-2020

Keywords

Preventative Care, Oncology, Quality Improvement, Family Medicine, Internal Medicine, Pulmonology

Disciplines

Family Medicine | Neoplasms | Oncology

Abstract

In the U.S., excluding melanoma, lung cancer is the leading cause of cancer-related deaths.¹
Cigarette smoking is the number one risk factor and is linked to 80-90% of lung cancer deaths.²
Low-dose Computerized Tomography has been shown to reduce lung cancer deaths by 20% in randomized control trials and observational studies.⁴
The U.S. Preventative Task Force recommends annual screening for lung cancer with low-dose computerized tomography (LDCT) in adults ages 55-80 years of age who:

• Have a 30 pack-year smoking history and
• Currently smoke or
• Have quit within the past 15 years.

Recommended Citation

LeBoutillier, Roshni; Savla, Bansi; Wu, Vincent; Khan, Zia; Mejia, Erick; Tehranchi, Leah; Myers, My; Min, Khine; Broyles, Jennifer; and Chase, Stacy, "Evaluating Awareness of Low-Dose Computerized Tomography For Lung Cancer Screening" (2020). West Florida Division GME Research Day 2020. 15.
https://scholarlycommons.hcahealthcare.com/westflorida2020/15